News & Analysis as of

Drug & Alcohol Abuse Health Care Providers

Arnall Golden Gregory LLP

AGG Talks: Healthcare Insights Podcast - Episode 2: Substance Use Disorder Litigation

In this episode AGG Healthcare Litigation co-chair Jason Bring is joined by AGG Healthcare Litigation partners Rich Collins and Damon Eisenbrey to discuss substance use disorder (“SUD”) litigation. The attorneys dive into...more

Venable LLP

Sharing of Addiction Treatment Records Gets Biden HHS Overhaul

Venable LLP on

After a nearly two-year delay, the U.S. Department of Health & Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Office for Civil Rights, promulgated a Final Rule...more

Manatt, Phelps & Phillips, LLP

Changes to the Substance Use Disorder Confidentiality Regulation: Implications for Stakeholders

Last week, the Department of Health and Human Services (HHS) released a final rule intended to implement a 2020 modification to the federal substance use disorder (SUD) privacy statute. The final rule more closely aligns the...more

Robinson+Cole Health Law Diagnosis

HHS Finalizes Updates to “Part 2” Regulations to Align Disclosure Rules with HIPAA and Promote More Coordinated Substance Use...

On February 8, 2024, the U.S. Department of Health and Human Services (HHS) issued a final rule (Final Rule) updating federal “Part 2” regulations to more closely align the requirements applicable to substance use disorder...more

Brownstein Hyatt Farber Schreck

Part 2 Redo: HHS Issues Rulemaking on SUD Privacy Laws

For years, federal privacy laws relating to substance abuse disorder (SUD) treatment records have differed in significant ways from federal privacy laws relating to other medical records. Changes, however, are afoot. Almost...more

Akin Gump Strauss Hauer & Feld LLP

Outlook for Action on Mental Health and Substance Use Disorder Initiatives

Prompted by rising rates of overdose deaths, suicides and incidence of mental illness in at-risk populations, such as children, Congress has spent the better part of the year working in a bipartisan manner to develop and...more

Stevens & Lee

Updates to PA’s Mental Health and Substance Use Disorder Confidentiality Laws

Stevens & Lee on

On July 7, 2022, Pennsylvania Governor Tom Wolf signed House Bills 1561 and 1563 into law, as Act 32 of 2022 and Act 33 of 2022, respectively. Act 32 of 2022 amended the confidentiality provisions of the state Mental Health...more

Manatt, Phelps & Phillips, LLP

[Webinar] The Substance Abuse Epidemic Among Youth: Responding to a Growing Mental Health Crisis - July 27th, 1:00 pm - 2:00 pm ET

Last year, the number of overdose deaths in the United States exceeded 100,000 for the first time ever. Equally alarming, the rate of drug-related overdose deaths among U.S. teenagers nearly doubled in 2020. Since that time,...more

Pullman & Comley - Connecticut Health Law

Regulatory Reminder: New CT Health Care Laws Effective July 1

The most recent legislative session of the Connecticut General Assembly produced a number of new statutory provisions impacting the operations of hospitals, physician groups and other health care providers. To help remind the...more

Nossaman LLP

CDC Updates Guidance on Opioid Prescriptions

Nossaman LLP on

In a shift from prior policy, the Centers for Disease Control and Prevention (CDC) proposed on February 22, 2022, new guidelines for prescribing opioid painkillers. The new guidance largely avoids figures on dosage strength...more

Manatt, Phelps & Phillips, LLP

State Toolkit to End the Nation’s Drug Overdose Epidemic: Leading-Edge Actions and Strategies to Remove Barriers to Evidence-based...

With drug overdose deaths reaching record numbers, policymakers and other stakeholders must increase their efforts to end the nation’s drug overdose epidemic with targeted, evidence-based interventions and emerging best...more

Manatt, Phelps & Phillips, LLP

[Webinar] Actions and Strategies to End the Nation’s Drug Overdose Epidemic - February 7th, 1:00 pm - 2:00 pm ET

The nation’s overdose and death epidemic continues to get worse, but policymakers and other stakeholders have yet to fully embrace evidence-based solutions to help those with a substance use disorder (SUD), patients with pain...more

Patrick Malone & Associates P.C. | DC Injury...

Opioid court cases offer hard evidence: Path to justice can be rocky

Patients who say they were injured by wealthy corporations must possess great fortitude as they seek justice in the civil system, as has been reaffirmed by the courts in California and Oklahoma that rejected separate cases...more

Manatt, Phelps & Phillips, LLP

[Webinar] Telehealth and SUD: Lessons From the Pandemic - October 7th, 4:00 pm - 5:00 pm ET

A New Webinar From the AMA and Manatt Shares How Telehealth Policies Changed During COVID-19, What That Means for Substance Use Disorder Treatment—and What’s Next... The COVID-19 pandemic drove significant expansion in...more

Patrick Malone & Associates P.C. | DC Injury...

U.S. ends confusion and expands prescribing of opioid-fighting medication

Health workers with legal prescribing privileges have gotten newly revised federal guidelines — once again — making it easier for them to help those addicted to powerful opioid painkillers by prescribing buprenorphine,...more

Patrick Malone & Associates P.C. | DC Injury...

Consultant to pay $573.9 million as consequence of its sketchy opioid advice

The opioid abuse and drug overdose crisis has tarred yet another of the nation’s business titans: McKinsey, a globally renowned consulting firm, has discovered that providing corporate clients sketchy advice about addictive,...more

Patrick Malone & Associates P.C. | DC Injury...

U.S. suit accuses Walmart of fueling deadly opioid crisis via its pharmacies

The stain of the nation’s opioid abuse and drug overdose crisis has spread now to Bentonville, Ark., as federal prosecutors have sued Walmart, accusing the nation’s largest retailer of improperly allowing its pharmacists to...more

Patrick Malone & Associates P.C. | DC Injury...

Consultants apologize for opioid hype, as pharma payments take more fire

Heaps of ignominy are not in short order for parties that played sketchy roles in fostering the nation’s deadly opioid abuse and drug overdose crisis. The stain has spread now to one of corporate America’s most-favored...more

Mintz - Health Care Viewpoints

HHS Further Amends 42 CFR Part 2, Easing Some, But Not All, Burdens on Substance Use Disorder Treatment Providers

The U.S. Department of Health and Human Services (HHS) recently released a final rule further amending 42 CFR Part 2 regulations (Part 2) to allow greater sharing of patient records related to substance use disorder (SUD)...more

Patrick Malone & Associates P.C. | DC Injury...

Drug maker to pay $1.6 billion to settle claims over its big role in opioids crisis

The civil justice system has scored a win in curtailing what once was a major maker of much abused and lethal prescription painkillers: Mallinckrodt, a global drug making giant, has agreed to send its opioids-making generics...more

Polsinelli

Changes Coming For Prescribers To The Texas Prescription Drug Monitoring Program

Polsinelli on

In response to the opioid epidemic, many states, including Texas, created prescription drug monitoring programs to monitor high-risk patients and provider behaviors. The Texas Prescription Drug Monitoring Program (“PMP”) is...more

Jones Day

February 2, 2020 is Here: Are Your Agreements Compliant With the Part 2 Rule?

Jones Day on

The Situation: The two-year grace period for updating agreements of "lawful holders" (i.e., recipients named on patient consent forms obtained pursuant to the Part 2 Rule) with contractors, subcontractors, and legal...more

Baker Donelson

The Nightmare Came True: Minor Licensing Actions Could Lead to Disastrous Collateral Damages

Baker Donelson on

As forewarned, CMS's finalization of the Calendar Year (CY) 2020 Physician Fee Schedule, effective January 1, 2020, brings significant changes to its authority to deny or revoke a Medicare enrollment for physicians and other...more

Seyfarth Shaw LLP

Sixth Circuit Allows Appeal Of Novel Class Action Ordered In Nationwide Opiate Litigation

Seyfarth Shaw LLP on

Seyfarth Synopsis: In the latest development in the ultra-high stakes nationwide Prescription Opiate Litigation, the U.S. Court of Appeals for the Sixth Circuit recently granted the petition of six Ohio cities to appeal the ...more

Harris Beach PLLC

Why We Support Take Back Day

Harris Beach PLLC on

The Drug Enforcement Agency’s National Prescription Drug Take Back Day is tomorrow: Saturday, October 26. This day has evolved over the years to address the growing opioid crisis, including misuse and abuse of unused...more

124 Results
 / 
View per page
Page: of 5

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide